Login
$HRGN
$2.35 +$0.05 (2.17%) Close

$HRGN 8-K/A SEC Filings

Filed On Filing
03 Aug 2026 8-K/A: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation

On April 13, 2026, Harvard Apparatus Regenerative Technology, Inc. (the “Company”) entered into a loan arrangement with Junli He, the Chairman and Chief Executive Officer of the Company (the “Lender”), pursuant to which the Lender agreed...

10 Jul 2023 8-K/A: Unregistered Sales of Equity Securities; Departure/Election of Directors or Officers; Compensation

This Amendment No. 1 to Employment Agreement (this “Amendment”) is entered as of July 10, 2023, with a deemed effective date as of March 14, 2023, to amend the Employment Agreement by and between Biostage, Inc., a Delaware corporation (t...

20 Sep 2022 8-K/A: Submission of Matters to a Vote of Security Holders

As previously reported in the Original Form 8-K, in a non-binding advisory vote on the frequency of future say on pay votes held at the 2022 Annual Meeting, 7,539,731 shares voted for one year, 1,684 shares voted for two years, 28,038 sh...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support